[1] Hou YJ, Yang XX, Liu RQ, et al. Pathological mechanism of photodynamic therapy and photothermal therapy based on nanoparticles [J]. Int J Nanomedicine, 2020, 15: 6827-6838. [2] Donohoe C, Senge M, Arnaut L, et al. Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunity [J]. Biochim Biophys Acta Rev Cancer, 2019, 1872(2): 188308. [3] 韦帝远,闫志敏.光动力疗法在口腔念珠菌病中的应用前景及研究进展[J].口腔医学研究, 2020, 36(12): 1087-1090. [4] Jin X, Xu H, Deng J, et al. Photodynamic therapy for oral potentially malignant disorders [J]. Photodiagnosis Photodyn Ther, 2019, 28: 146-152. [5] Cerrati EW, Nguyen SA, Farrar JD, et al. The efficacy of photodynamic therapy in the treatment of oral squamous cell carcinoma: a meta-analysis [J]. Ear Nose Throat J, 2015, 94(2): 72-79. [6] Kessel D. Subcellular targeting as a determinant of the efficacy of photodynamic therapy [J]. Photochem Photobiol, 2017, 93(2): 609-612. [7] Dirschka T, Ekanayake-Bohlig S, Dominicus R, et al. A randomized, intraindividual, non-inferiority, Phase Ⅲ study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis [J]. J Eur Acad Dermatol Venereol, 2019, 33(2): 288-297. [8] Radakovic S, Dangl M, Tanew A. 5-Aminolevulinic acid patch (Alacare) photodynamic therapy for actinic cheilitis: data from a prospective 12-month follow-up study on 21 patients [J]. J Eur Acad Dermatol Venereol, 2020, 34(9): 2011-2015. [9] Juzeniene A, Moan J. The history of PDT in Norway Part Ⅱ. Recent advances in general PDT and ALA-PDT [J]. Photodiagnosis Photodyn Ther, 2007, 4(2): 80-87. [10] Champeau M, Jary D, Mortier L, et al. A facile fabrication of dissolving microneedles containing 5-aminolevulinic acid [J]. Int J Pharm, 2020, 586: 119554. [11] Fan W, Huang P, Chen X. Overcoming the Achilles' heel of photodynamic therapy [J]. Chem Soc Rev, 2016, 45(23): 6488-6519. [12] Yan T, Liu Z, Song X, et al. Construction and development of tumor microenvironment stimulus-responsive upconversion photodynamic diagnosis and treatment system [J]. Acta Chimica Sinica, 2020, 78(7): 657. [13] Zhang Y, Huang W, Tan X, et al. A mitochondria-targeted dual-functional aggregation-induced emission luminogen for intracellular mitochondrial imaging and photodynamic therapy [J]. Biomater Sci, 2021, 9(4):1232-1236. [14] Yu J, Yin W, Zheng X, et al. Smart MoS2/Fe3O4 nanotheranostic for magnetically targeted photothermal therapy guided by magnetic resonance/photoacoustic imaging [J]. Theranostics, 2015, 5(9): 931-945. [15] Bisland SK, Lilge L, Lin A, et al. Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors [J]. Photochem Photobiol, 2004, 80: 22-30. [16] Liu WL, Liu T, Zou MZ, et al. Aggressive man-made red blood cells for hypoxia-resistant photodynamic therapy [J]. Adv Mater, 2018, 30(35): e1802006. [17] Zhao LP, Zheng RR, Chen HQ, et al. Self-delivery nanomedicine for O2-economized photodynamic tumor therapy [J]. Nano Lett, 2020, 20(3): 2062-2071. [18] Lv W, Xia H, Zhang KY, et al. Photothermal-triggered release of singlet oxygen from an endoperoxide--containing polymeric carrier for killing cancer cells [J]. Mater Horiz, 2017,4:1185-1189. [19] Sun Z, Zhang LP, Wu F, et al. Photosensitizers for two-photon excited photodynamic therapy [J]. Adv Funct Mater, 2017, 27(48): 1704079. [20] Sokolovski SG, Zolotovskaya SA, Goltsov A, et al. Infrared laser pulse triggers increased singlet oxygen production in tumour cells [J]. Sci Rep, 2013, 3: 3484. [21] Huang Y, Qiu F, Chen R, et al. Fluorescence resonance energy transfer-based drug delivery systems for enhanced photodynamic therapy [J]. J Mater Chem B, 2020, 8(17): 3772-3788. [22] Cline B, Delahunty I, Xie J. Nanoparticles to mediate X-ray-induced photodynamic therapy and Cherenkov radiation photodynamic therapy [J]. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2019, 11(2): e1541. [23] Yamagishi K, Kirino I, Takahashi I, et al. Tissue-adhesive wirelessly powered optoelectronic device for metronomic photodynamic cancer therapy [J]. Nat Biomed Eng, 2019, 3(1): 27-36. [24] Liu Z, Xu L, Zheng Q, et al. Human motion driven self-powered photodynamic system for long-term autonomous cancer therapy [J]. ACS nano, 2020, 14(7): 8074-8083. [25] Canavesi C, Fournier F, Cassarly W, et al. Illumination devices for photodynamic therapy of the oral cavity [J]. Biomed Opt Express, 2010, 1(5): 1480-1490. [26] Quon H, Finlay J, Cengel K, et al. Transoral robotic photodynamic therapy for the oropharynx [J]. Photodiagnosis Photodyn Ther, 2011, 8(1): 64-67. [27] Chen HM, Yu CH, Tsai T, et al. Topical 5-aminolevulinic acid-mediated photodynamic therapy for oral verrucous hyperplasia, oral leukoplakia and oral erythroleukoplakia [J]. Photodiagnosis Photodyn Ther, 2007, 4(1): 44-52. [28] Yao Y, Shen X, Shi L, et al. The combination of photodynamic therapy and fractional CO2 laser for oral leukoplakia: Case series [J]. Photodiagnosis Photodyn Ther, 2020, 29: 101597. [29] Wang X, Han Y, Jin J, et al. Plum-blossom needle assisted photodynamic therapy for the treatment of oral potentially malignant disorder in the elderly [J]. Photodiagnosis Photodyn Ther, 2019, 25: 296-299. [30] Meulemans J, Delaere P, Vander Poorten V. Photodynamic therapy in head and neck cancer: indications, outcomes, and future prospects [J]. Curr Opin Otolaryngol Head Neck Surg, 2019, 27(2): 136-141. [31] Maytin EV,Hasan T. Vitamin D and other differentiation-promoting agents as neoadjuvants for photodynamic therapy of cancer [J]. Photochem Photobiol, 2020, 96(3): 529-538. |